ArticleAdvances in radiation oncology2026
Patient-Reported Outcomes After Radiation Therapy for Dupuytren's Contracture.
Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Dupuytren's contracture (DC) is a fibroproliferative disorder that can result in functional impairment of the hand. Radiation therapy (RT) is used to prevent disease progression and sometimes as adjuvant therapy after surgeries and recurrences. However, comprehensive data on patient-reported efficacy are limited. This study aimed to assess patient-reported outcomes in patients with DC treated with primary and adjuvant RT. Methods and Materials: A single-institution retrospective study was conducted, including 22 patients treated with RT for DC between April 2017 and July 2022. Surveys to assess satisfaction, perceived effectiveness, and treatment burden used Likert scales and the post-RT Southampton Dupuytren's Scoring Scheme. All patients received either 30 Gy in a split course or 21 Gy in continuous daily treatments. Results: Median follow-up was 4.3 years, and median age at diagnosis was 61 years. Sixty-three percent had undergone fasciectomy before RT. Seventy-seven percent expressed satisfaction with RT outcomes, and 68% perceived it as effective. Median post-RT Southampton Dupuytren's Scoring Scheme score was 5 (IQR, 4-6), indicating mild functional limitations. Four patients (18%) experienced new nodules or cords, and only 1 patient (4.5%) required further surgery. Thirteen patients (59%) reported side effects from RT, most commonly mild dry skin. One patient developed severe dry skin, but there were no other severe toxicities or malignancies observed. Conclusions: RT for DC may be associated with high patient satisfaction and low toxicity. Although these findings are encouraging, they are hypothesis-generating and warrant confirmation in prospective studies with larger cohorts and systematic pretreatment and posttreatment assessments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.